Supporting its relevance as a therapeutic target, single-cell transcriptomic analyses have identified elevated Rap1B expression in tumor-associated endothelial cells across multiple cancers, including lung, colorectal, and ovarian tumors [40,112,114]. This evidence concerns the gene RAP1B and neoplasm.